News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here.

Recommended Reading

How Accurately Do Current Criteria Identify CBD and PSP?
MDedge Neurology
Patisiran May Reduce Neuropathy in Patients With hATTR Amyloidosis
MDedge Neurology
FDA Efforts to Advance Development of Gene Therapies
MDedge Neurology
Risk of ALS May Increase With Greater Exposure to Diesel Exhaust
MDedge Neurology
Childhood Neuromuscular Disease as a Metaphor for the Scientific Advances in Child Neurology of the Last Quarter Century
MDedge Neurology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Neurology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Neurology
RFPs Available for the Study of Three Rare Diseases
MDedge Neurology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Neurology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Neurology